164 related articles for article (PubMed ID: 38672440)
1. Computational Modeling and Characterization of Peptides Derived from Nanobody Complementary-Determining Region 2 (CDR2) Targeting Active-State Conformation of the β
Sencanski M; Glisic S; Kubale V; Cotman M; Mavri J; Vrecl M
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672440
[TBL] [Abstract][Full Text] [Related]
2. Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the β
Sencanski M; Glisic S; Šnajder M; Veljkovic N; Poklar Ulrih N; Mavri J; Vrecl M
Sci Rep; 2019 Nov; 9(1):16555. PubMed ID: 31719570
[TBL] [Abstract][Full Text] [Related]
3. Studies on the interactions between β2 adrenergic receptor and Gs protein by molecular dynamics simulations.
Feng Z; Hou T; Li Y
J Chem Inf Model; 2012 Apr; 52(4):1005-14. PubMed ID: 22404225
[TBL] [Abstract][Full Text] [Related]
4. Regulation of β2-adrenergic receptor function by conformationally selective single-domain intrabodies.
Staus DP; Wingler LM; Strachan RT; Rasmussen SG; Pardon E; Ahn S; Steyaert J; Kobilka BK; Lefkowitz RJ
Mol Pharmacol; 2014 Mar; 85(3):472-81. PubMed ID: 24319111
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of β
Susec M; Sencanski M; Glisic S; Veljkovic N; Pedersen C; Drinovec L; Stojan J; Nøhr J; Vrecl M
Neuropharmacology; 2019 Jul; 152():78-89. PubMed ID: 30707913
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane helix 6 observed at the interface of β2AR homodimers in blind docking studies.
Koroglu A; Akten ED
J Biomol Struct Dyn; 2015; 33(7):1503-15. PubMed ID: 25262920
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of pepducins as Gs-biased allosteric agonists.
Carr R; Du Y; Quoyer J; Panettieri RA; Janz JM; Bouvier M; Kobilka BK; Benovic JL
J Biol Chem; 2014 Dec; 289(52):35668-84. PubMed ID: 25395624
[TBL] [Abstract][Full Text] [Related]
8. Computational study on the different ligands induced conformation change of β2 adrenergic receptor-Gs protein complex.
Bai Q; Zhang Y; Ban Y; Liu H; Yao X
PLoS One; 2013; 8(7):e68138. PubMed ID: 23922653
[TBL] [Abstract][Full Text] [Related]
9. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.
Staus DP; Strachan RT; Manglik A; Pani B; Kahsai AW; Kim TH; Wingler LM; Ahn S; Chatterjee A; Masoudi A; Kruse AC; Pardon E; Steyaert J; Weis WI; Prosser RS; Kobilka BK; Costa T; Lefkowitz RJ
Nature; 2016 Jul; 535(7612):448-52. PubMed ID: 27409812
[TBL] [Abstract][Full Text] [Related]
10. Search for β2 adrenergic receptor ligands by virtual screening via grid computing and investigation of binding modes by docking and molecular dynamics simulations.
Bai Q; Shao Y; Pan D; Zhang Y; Liu H; Yao X
PLoS One; 2014; 9(9):e107837. PubMed ID: 25229694
[TBL] [Abstract][Full Text] [Related]
11. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5.
Bolger GB; Baillie GS; Li X; Lynch MJ; Herzyk P; Mohamed A; Mitchell LH; McCahill A; Hundsrucker C; Klussmann E; Adams DR; Houslay MD
Biochem J; 2006 Aug; 398(1):23-36. PubMed ID: 16689683
[TBL] [Abstract][Full Text] [Related]
12. Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.
Gimenez LE; Baameur F; Vayttaden SJ; Clark RB
Mol Pharmacol; 2015 Jun; 87(6):954-64. PubMed ID: 25784721
[TBL] [Abstract][Full Text] [Related]
13. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
14. β2-Adrenergic Receptors Chaperone Trapped Bitter Taste Receptor 14 to the Cell Surface as a Heterodimer and Exert Unidirectional Desensitization of Taste Receptor Function.
Kim D; Pauer SH; Yong HM; An SS; Liggett SB
J Biol Chem; 2016 Aug; 291(34):17616-28. PubMed ID: 27342779
[TBL] [Abstract][Full Text] [Related]
15. Cysteine redox state regulates human β2-adrenergic receptor binding and function.
Rambacher KM; Moniri NH
Sci Rep; 2020 Feb; 10(1):2934. PubMed ID: 32076070
[TBL] [Abstract][Full Text] [Related]
16. Tyr199 in transmembrane domain 5 of the beta2-adrenergic receptor interacts directly with the pharmacophore of a unique fluorenone-based antagonist.
Wu Z; Thiriot DS; Ruoho AE
Biochem J; 2001 Mar; 354(Pt 3):485-91. PubMed ID: 11237852
[TBL] [Abstract][Full Text] [Related]
17. An Intracellular Tripeptide Arg-His-Trp of Serum Origin Detected in MCF-7 Cells is a Possible Agonist to β2 Adrenoceptor.
Chandore H; Raj AK; Lokhande KB; Swamy KV; Pal JK; Sharma NK
Protein Pept Lett; 2021; 28(10):1191-1202. PubMed ID: 34397320
[TBL] [Abstract][Full Text] [Related]
18. Identification of a key amino acid of the beta2-adrenergic receptor for high affinity binding of salmeterol.
Isogaya M; Yamagiwa Y; Fujita S; Sugimoto Y; Nagao T; Kurose H
Mol Pharmacol; 1998 Oct; 54(4):616-22. PubMed ID: 9765503
[TBL] [Abstract][Full Text] [Related]
19. Insights into the role of Asp79(2.50) in β2 adrenergic receptor activation from molecular dynamics simulations.
Ranganathan A; Dror RO; Carlsson J
Biochemistry; 2014 Nov; 53(46):7283-96. PubMed ID: 25347607
[TBL] [Abstract][Full Text] [Related]
20. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor.
Seifert R; Wenzel-Seifert K; Lee TW; Gether U; Sanders-Bush E; Kobilka BK
J Biol Chem; 1998 Feb; 273(9):5109-16. PubMed ID: 9478963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
